Illumina, Spark Therapeutics and Endo International were among the biotech stock movers in premarket trading on Aug. 2.
I spent the weekend with thousands of blood disease researchers. This is what happened.
Spark believes temporary treatment with steroids can arrest the immune response before it causes factor IX levels to fall to a point where bleeding risk becomes a problem.
The American Society of Hematology (ASH) annual meeting is one of the most important medical conferences held each year, focusing on new drugs to treat blood-related diseases, including blood cancers.